Session Details
[P-RT]Retro
Tue. Oct 29, 2019 11:00 AM - 5:00 PM JST
Tue. Oct 29, 2019 2:00 AM - 8:00 AM UTC
Tue. Oct 29, 2019 2:00 AM - 8:00 AM UTC
Poster Room Exhibition Hall
Viewing
[P-RT-01]A marine compound, portimine, is a potent anti-HIV-1 therapeutic seed.
*Mai Izumida1, Yoshinao Kubo1, Fumito Ishibashi2, Koushiou Suga2 (1. Institute of Tropical Medicine Nagasaki University, 2. Graduate school of fisheries and environmental sciences, Nagasaki University)
[P-RT-02]Structural Interference of Polymorphic R105G in Antiviral APOBEC3H
*Hirotaka Ode1, Yoshihiro Nakata1,2, Kazuhiro Matsuoka1, Mayumi Imahashi1, Atsuko Hachiya1, Yoshiyuki Yokomaku1, Yasumasa Iwatani1,2 (1. National Hospital Organization Nagoya Medical Center, 2. Nagoya University Graduate School of Medicine)
[P-RT-03]Establishment of latently HIV-1-infected cell lines
*Shohei Suzuki1, Fumitaka Momose1,2, Yuko Morikawa1,2 (1. Graduate School of Infection Control Sciences, Kitasato University, 2. Kitasato Institute for Life Sciences, Kitasato University)
[P-RT-04]Characterization of the heterogeneity of HIV-1-infected cells in vivo
*Hirofumi Aso1,2,3, Shumpei Nagaoka3, Jumpei Ito3, Naoko Misawa1, Katsuyuki Shiroguchi4,5, Yutaka Suzuki6, Eiryo Kawakami7,8, Yoshio Koyanagi1,2, Kei Sato3,9 (1. Laboratory of Systems Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan, 2. Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan, 3. Division of Systems Virology, Department of Infectious Disease Control, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 4. Laboratory for Prediction of Cell Systems Dynamics, RIKEN Center for Biosystems Dynamics Research (BDR), Osaka, Japan, 5. Laboratory for Immunogenetics, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan, 6. Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, Graduate school of Frontier Sciences, The University of Tokyo, Tokyo, Japan, 7. Medical Sciences Innovation Hub Program (MIH), RIKEN, Kanagawa, Japan, 8. Department of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan, 9. CREST, Japan Science and Technology Agency, Saitama, Japan)
[P-RT-05]Immunological analysis of AIDS-like diseases in SIV infected simianized mice
*Yuzuki Miura1, Haruka Yokoyama1, Sho Sekine1, Hiromi Sakawaki1, Tomoyuki Miura1, Kentaro Ibuki1 (1. Kyoto university)
[P-RT-06]Analysis of molecular mechanism on species-specific growth enhancement by a single-amino acid mutation in V3 tip of CCR5-tropic HIV-1 Env
*Naoya Doi1, Takaaki Koma1, Akio Adachi2, Masako Nomaguchi1 (1. Tokushima University, 2. Kansai Medical University)
[P-RT-07]Characterization of CD4+ T-cell death induced in the early phase of HIV-1 infection using a humanized mouse model
*Yushi Sato1,2, Kazutaka Terahara1, Ryutaro Iwabuchi1,3, Yuko Morikawa2, Yasuko Tsunetsugu-Yokota1,4 (1. Department of Immunology, National Institute of Infectious Diseases, 2. Laboratory of Viral Infection II, Graduate School of Infection Control Science, Kitasato University, 3. Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, 4. Department of Medical Technology, School of Human Sciences, Tokyo University of Technology)
[P-RT-08]PLSCR1 interacts with P-TEFb and represses the Tat-independent transcription from HIV-1 LTR
*Shuichi Kusano1, Masanori Ikeda1 (1. Kagoshima University)
[P-RT-09]Molecular bases on determination of Vif expression levels by single-nucleotide mutations within SA1D2prox and adaptive mutations on the HIV-1 genome
*Masako Nomaguchi1, Takaaki Koma1, Naoya Doi1, Hideki Yamamoto2, Kyosuke Watanabe2, Mai Takemoto2, Akio Adachi3 (1. Tokushima University Graduate School of Medical Science, 2. Tokushima University Faculty of Medicine, 3. Kansai Medical University)
[P-RT-10]Biochemical characteristics of ARIH2 in HIV-1 Vif mediated APOBEC3-ubiquitination
*Kazuhiro Matsuoka1, Hirotaka Ode1, Yoshihiro Nakata1,2, Atsuko Hachiya1, Mayumi Imahashi1, Yoshiyuki Yokomaku1, Yasumasa Iwatani1,2 (1. Clinical Research Center, National Hospital Organization Nagoya Medical Center, 2. Department of AIDS Research, Nagoya University Graduate School of Medicine, Nagoya)
[P-RT-11]Poly-proline motif in HIV-2 Vpx suppresses proteasome degradation of the protein in the absence of Gag
*Kazunori Shimagaki1, Ryoko Kogo1, Haruna Fujino1, Halil Ibrahim Ciftci1, Minami Yamamoto1, Hiroshi Tateishi1, Masami Otsuka1, Yoshihiro Yamaguchi2, Mikako Fujita1 (1. Medicinal and Biological Chemistry Science Farm Joint Research Laboratory Faculty of Life Sciences, Kumamoto University, 2. Environmental Safety Center, Kumamoto University)
[P-RT-12]Investigation of proviral features of HIV-1 infected cells in vivo
*Shumpei Nagaoka1, Jumpei Ito1, Naoko Misawa6, Saiful Islam4,5, Hirofumi Aso3,6, Yorifumi Satou5,4, Yoshio Koyanagi6, Kei Sato1,2 (1. Division of Systems Virology, Department of Infectious Disease Control, Institute of Medical Science, The University of Tokyo, 2. JST CREST, 3. Graduate School of Pharmaceutical Sciences, Kyoto University, 4. International Research Center for Medical Sciences (IRCMS), Kumamoto University, 5. Center for AIDS Research, Kumamoto University, 6. Laboratory of Systems Virology, Institute for Frontier Life and Medical Sciences, Kyoto University)
[P-RT-13]Exploration for assembly-promoting factors involved in the early stage of HIV-1 Gag assembly
*Takaaki Koma1, Naoya Doi1, Satoshi Nakashima2, Akio Adachi3, Masako Nomaguchi1 (1. Department of Microbiology, Tokushima University Graduate School of Medical Science , 2. Tokushima University Faculty of Medicine, 3. Department of Microbiology, Kansai Medical University)
[P-RT-14]Investigation of the difference on the molecular mechanism of HIV-1 budding between viral subtypes
*Yoriyuki Konno1, Keiya Uriu2, Eiji Morita2, Yoshio Koyanagi3, Kei Sato1,4 (1. Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, 2. Department of Biochemistry and Molecular Biology, Faculty of Agriculture and Life Science, Hirosaki University, 3. Laboratory of Systems Virology, Department of Biosystems Science, Institute for Frontier Life and Medical Sciences, Kyoto University, 4. CREST, Japan Science and Technology Agency, Saitama, Japan)
[P-RT-15]Prediction of molecular dynamics based structural models of the Pr55Gagprecursor of HIV-1
*Osamu Kotani1, Masaru Yokoyama1, Akira Ono2, Hironori Sato1 (1. National Institute of Infectious Diseases, 2. University of Michigan Medical School)
[P-RT-16]Maternal antibodies induced by immunization with recombinant HTLV-1 Env protein in mice
*Akira Ainai1, Kumpei Saito1, Tadaki Suzuki1, Hideki Hasegawa1 (1. Department of Pathology, National Institute of Infectious Diseases)
[P-RT-17]Functional analysis of syndecan in cell-to-cell spread of murine leukemia virus
*Chie Taguchi1, Hiroki Saitou1, Shinichi Kaji1, Yasuhiko Hayashi1, Hidekazu Inoue1, Atsushi Tanaka2, Sayaka Takase-Yoden1 (1. Department of Bioinformatics, Graduate school of Engineering, Soka university, 2. Research Institute for Microbial Diseases, Osaka University)
[P-RT-18]Function of 11nt region within gag gene in splicing of murine leukemia virus
*Masao Hasegawa1, Yuko Honma1, Sayaka Takase-Yoden1 (1. Department of Bioinformatics, Graduate School of Engineering, Soka University)
[P-RT-19]Analysis of cis-elements involved in polysome formation of full-length mRNA of murine leukemia virus
*Sachie Torii1, Kenshi Aburatani1, Sayaka Takase-Yoden1 (1. Department of Bioinformatics, Graduate School of Engineering, Soka University)
[P-RT-20]L233P mutaion of bovine leukemia virus Tax depressed annexine A3 secretion from the host cells
*Tomiyasu Tomiyasu1, Hiroshi Mori1, Katsunori OKAZAKI1 (1. Health Sciences University of Hokkaido)
[P-RT-21]Analysis of viral replication regulating factors in bovine leukemia virus using chemical biology approach
*Makoto Murakami1, Sinji Kamisuki1, Kenji Tsukamoto1, Hironobu Murakami1 (1. Azabu university)
[P-RT-22]Detection of novel viral SNPs correlated with proviral load in BLV infected cattle.
*Kiyohiko ANDOH1, Asami Nishimori1, Masataka Akagami2,3, Shinichi Hatama1 (1. National Institute of Animal Health, NARO, 2. Ibaraki Prefecture Kenpoku Livestock Hygiene Service Center, 3. Ibaraki Prefecture Kennan Livestock Hygiene Service Center)
[P-RT-23]CAT1/SLC7A1 acts as a cellular receptor for bovine leukemia virus infection
*Lanlan Bai1, Sato Hirotaka2, Kubo Yoshinao3, Wada Satoshi1, Aida Yoko2 (1. Photonics Control Technology Team, RIKEN Center for Advanced Photonics, 2. Nakamura Laboratory, Baton Zone Program, RIKEN Cluster for Science, Technology and Innovation Hub, 3. Program for Nurturing Global Leaders in Tropical Medicine and Emerging Communicable Diseases, Graduate School of Biomedical Sciences, Nagasaki University)
[P-RT-24]Identification of an ERV-containing human transcript induced by vaccination
*Tomoyuki Honda1, Keiko Takemoto2, Keiji Ueda1 (1. Osaka University, 2. Kyoto University)
[P-RT-25]Identification of HERV-K integration sites by retrotransposition in SOX2-expressing cells
*Kazuaki Monde1, Yorifumi Satou2, Yoshikazu Uchiyama3, Mizuki Goto5, Takumi Era5, Ito Jumpei6, Itsurou Inoue6, Taku Kaitsuka4, Kazuhito Tomizawa4, Hiromi Terasawa1, Tomohiro Sawa1, Yosuke Maeda1 (1. Department of Microbiology, Faculty of Life Sciences, Kumamoto University, 2. International Research Center for Medical Sciences, Kumamoto University, 3. Department of Medical Physics, Kumamoto University, 4. Department of Molecular Physiology, Faculty of Life Sciences, Kumamoto University, 5. Department of Cell Modulation, Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, 6. National Institute of Genetics Division of Human Genetics)